Federation des caisses Desjardins du Quebec’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$752K Sell
13,315
-1,822
-12% -$106K ﹤0.01% 1109
2025
Q4
$900K Sell
15,137
-183
-1% -$9.96K ﹤0.01% 1031
2025
Q3
$830K Buy
15,320
+6,860
+81% +$392K ﹤0.01% 1020
2025
Q2
$465K Sell
8,460
-12,973
-61% -$764K ﹤0.01% 1056
2025
Q1
$1.52M Buy
21,433
+6,960
+48% +$468K 0.01% 706
2024
Q4
$951K Buy
14,473
+5,884
+69% +$394K ﹤0.01% 807
2024
Q3
$604K Buy
8,589
+991
+13% +$82.8K ﹤0.01% 908
2024
Q2
$626K Buy
7,598
+2,398
+46% +$200K ﹤0.01% 882
2024
Q1
$458K Buy
5,200
+1,050
+25% +$94K ﹤0.01% 903
2023
Q4
$400K Sell
4,150
-1,791
-30% -$158K ﹤0.01% 830
2023
Q3
$526K Sell
5,941
-639
-10% -$56.9K 0.01% 740
2023
Q2
$570K Sell
6,580
-669
-9% -$63K 0.01% 730
2023
Q1
$705K Buy
7,249
+4,830
+200% +$501K 0.01% 679
2022
Q4
$250K Buy
2,419
+300
+14% +$28.2K ﹤0.01% 967
2022
Q3
$180K Sell
2,119
-188
-8% -$16.7K ﹤0.01% 1121
2022
Q2
$191K Sell
2,307
-80
-3% -$6.37K ﹤0.01% 1130
2022
Q1
$184K Buy
2,387
+200
+9% +$16.7K ﹤0.01% 1167
2021
Q4
$193K Hold
2,187
﹤0.01% 1164
2021
Q3
$169K Buy
2,187
+1,537
+236% +$121K ﹤0.01% 1215
2021
Q2
$54.2K Sell
650
-1,037
-61% -$82.2K ﹤0.01% 1585
2021
Q1
$127K Sell
1,687
-50
-3% -$4.08K ﹤0.01% 1257
2020
Q4
$152K Buy
1,737
+987
+132% +$78.3K ﹤0.01% 1144
2020
Q3
$57.1K Buy
750
+400
+114% +$40.5K ﹤0.01% 1201
2020
Q2
$43.2K Hold
350
﹤0.01% 1251
2020
Q1
$29.6K Hold
350
﹤0.01% 1403
2019
Q4
$29.6K Hold
350
﹤0.01% 1643
2019
Q3
$23.6K Hold
350
﹤0.01% 1636
2019
Q2
$30K Hold
350
﹤0.01% 1611
2019
Q1
$31.1K Hold
350
﹤0.01% 1425
2018
Q4
$29.8K Hold
350
﹤0.01% 1401
2018
Q3
$33.9K Hold
350
﹤0.01% 1442
2018
Q2
$33K Hold
350
﹤0.01% 1445
2018
Q1
$28.4K Buy
+350
New +$30K ﹤0.01% 1480
2017
Q4
Sell
-100
Closed -$9.31K 2136
2017
Q3
$9.31K Hold
100
﹤0.01% 1692
2017
Q2
$9.08K Hold
100
﹤0.01% 1760
2017
Q1
$8.78K Buy
+100
New +$8.9K ﹤0.01% 1450

Other funds holding BMRN